Cargando…

Mortality and Morbidity in HFrEF, HFmrEF, and HFpEF Patients with Diabetes in the Middle East

OBJECTIVES: We sought to estimate the mortality and morbidity in diabetic acute heart failure (AHF) patients stratified by left ventricular ejection fraction. METHODS: We analyzed the data of patients with AHF from seven Middle Eastern countries (Bahrain, Oman, Yemen, Kuwait, UAE, Qatar, and Saudi A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Jarallah, Mohammed, Rajan, Rajesh, Al-Zakwani, Ibrahim, Dashti, Raja, Bulbanat, Bassam, Ridha, Mustafa, Sulaiman, Kadhim, Alsheikh-Ali, Alawi A., Panduranga, Prashanth, AlHabib, Khalid F., Al Suwaidi, Jassim, Al-Mahmeed, Wael, AlFaleh, Hussam, Elasfar, Abdelfatah, Al-Motarreb, Ahmed, Bazargani, Nooshin, Asaad, Nidal, Amin, Haitham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	OMJ 2020
Materias:	Original Artcile
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026806/ https://www.ncbi.nlm.nih.gov/pubmed/32095280 http://dx.doi.org/10.5001/omj.2020.17

Ejemplares similares

Similarities and Differences Between HFmrEF and HFpEF
por: Li, Peixin, et al.
Publicado: (2021)

Editorial: HFpEF and HFmrEF: Different Sides of the Same Coin?
por: Martínez-Sellés, Manuel, et al.
Publicado: (2022)

Are HFpEF and HFmrEF So Different? The Need to Understand Distinct Phenotypes
por: Palazzuoli, Alberto, et al.
Publicado: (2021)

Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients
por: Grossekettler, Leonie, et al.
Publicado: (2020)

Locomotor and respiratory muscle abnormalities in HFrEF and HFpEF
por: Mangner, Norman, et al.
Publicado: (2023)

Different determinants of exercise capacity in HFpEF compared to HFrEF
por: Batalli, Arlind, et al.
Publicado: (2017)

CMR Tissue Characterization in Patients with HFmrEF
por: Doeblin, Patrick, et al.
Publicado: (2019)

Obesity increases cardiovascular mortality in patients with HFmrEF
por: Liu, Zhican, et al.
Publicado: (2022)

Impact of signs and symptoms on the prognosis of patients with HFmrEF
por: Liu, Zhican, et al.
Publicado: (2023)

A horse of a different colour: distinct mechanisms of HFpEF and HFrEF
por: Louch, William E.
Publicado: (2020)

Quality of life questionnaire predicts poor exercise capacity only in HFpEF and not in HFrEF
por: Ahmeti, Artan, et al.
Publicado: (2017)

Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical Outcomes
por: Kristensen, Søren L., et al.
Publicado: (2017)

Myocardial phenotypes and dysfunction in HFpEF and HFrEF assessed by echocardiography and cardiac magnetic resonance
por: Berlot, Bostjan, et al.
Publicado: (2019)

Disparate Clinical Characteristics and Prognosis of HFpEF versus HFrEF Phenotype of Diabetic Cardiomyopathy
por: Li, Zheng, et al.
Publicado: (2023)

The vasculature in HFpEF vs HFrEF: differences in contractile protein expression produce distinct phenotypes
por: Lyle, Melissa A., et al.
Publicado: (2019)

Ubiquitin‐proteasome‐system and enzymes of energy metabolism in skeletal muscle of patients with HFpEF and HFrEF
por: Adams, Volker, et al.
Publicado: (2021)

Left-Side Pressure Index for All-Cause Mortality in Older Adults with HFpEF: Diagnostic Potential for HFpEF and Possible View for HFrEF
por: Hoshida, Shiro
Publicado: (2023)

Cellular and Molecular Differences between HFpEF and HFrEF: A Step Ahead in an Improved Pathological Understanding
por: Simmonds, Steven J., et al.
Publicado: (2020)

Quantification of pulmonary edema in heart failure using MRI: invasive validation and evaluation in HFpEF and HFrEF patients
por: Thompson, Richard B, et al.
Publicado: (2016)

Patients with HFpEF and HFrEF have different clinical characteristics but similar prognosis: a retrospective cohort study
por: Abebe, Tamrat Befekadu, et al.
Publicado: (2016)

Differential Responses of Post-Exercise Recovery of Leg Blood Flow and Oxygen Uptake Kinetics in HFpEF versus HFrEF
por: Thompson, Richard B., et al.
Publicado: (2016)

Heart Failure with Reduced Ejection Fraction (HFrEF) and Preserved Ejection Fraction (HFpEF): The Diagnostic Value of Circulating MicroRNAs
por: Chen, Yei-Tsung, et al.
Publicado: (2019)

Asymptomatic Left Ventricular Hypertrophy Is a Potent Risk Factor for the Development of HFpEF but Not HFrEF: Results of a Retrospective Cohort Study
por: Ovchinnikov, Artem, et al.
Publicado: (2022)

Left atrial structure and function in heart failure with reduced (HFrEF) versus preserved ejection fraction (HFpEF): systematic review and meta-analysis
por: Jin, Xuanyi, et al.
Publicado: (2022)

Aiming at harmony. Comparing and contrasting International HFrEF Guidelines
por: Tomasoni, Daniela, et al.
Publicado: (2022)

Getting ahead of the game: in-hospital initiation of HFrEF therapies
por: Biegus, Jan, et al.
Publicado: (2022)

Is heart failure with mid range ejection fraction (HFmrEF) a distinct clinical entity or an overlap group?()
por: Webb, Jessica, et al.
Publicado: (2018)

Risk factors of short‐term, intermediate‐term, and long‐term cardiac events in patients hospitalized for HFmrEF
por: Zhu, Yunlong, et al.
Publicado: (2022)

Neprilysin in HFrEF: Differential Regulation of Tissue Versus Circulating Neprilysin
por: Chen, Horng H., et al.
Publicado: (2020)

Empagliflozin and HFrEF: Known and Possible Benefits of NHE1 Inhibition
por: Jun, Seungho, et al.
Publicado: (2019)

Association of Depression Symptoms and Biomarkers of Risk on Clinical Outcomes in HFrEF
por: Sherwood, Andrew, et al.
Publicado: (2023)

Corrigendum to: Aiming at harmony. Comparing and contrasting International HFrEF Guidelines
Publicado: (2023)

Predictors and Prognostic Value of Worsening Renal Function During Admission in HFpEF Versus HFrEF: Data From the KorAHF (Korean Acute Heart Failure) Registry
por: Kang, Jeehoon, et al.
Publicado: (2018)

Usefulness of High-Sensitivity Troponin I in Risk Stratification and Final Disposition of Patients with Acute Heart Failure in the Emergency Department: Comparison between HFpEF vs. HFrEF
por: Crisanti, Luca, et al.
Publicado: (2022)

Aging-Related Endothelial Progenitor Cell Dysfunction and Its Association with IL-17 and IL-23 in HFmrEF Patients
por: Zeng, Lijin, et al.
Publicado: (2022)

Large Animal Models of Heart Failure With Reduced Ejection Fraction (HFrEF)
por: Spannbauer, Andreas, et al.
Publicado: (2019)

Plasma Neprilysin Displays No Relevant Association With Neurohumoral Activation in Chronic HFrEF
por: Prausmüller, Suriya, et al.
Publicado: (2020)

FGF-23 is a biomarker of RV dysfunction and congestion in patients with HFrEF
por: Benes, Jan, et al.
Publicado: (2023)

Obesity and HFpEF
por: Clemenza, Francesco, et al.
Publicado: (2022)

Circulating Relaxin-1 Level Is a Surrogate Marker of Myocardial Fibrosis in HFrEF
por: Simon, Judit, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_62fie71lfvh3ko423blo6tu3v0